NicholasKaryotakisMD

Gastroenterology • Los Angeles, CA

Physician

Join to view full profile

Dr. Karyotakis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Karyotakis' full profile

Already have an account?

Office
2080 Century Park East
#1206
Los Angeles, CA 90067
Phone+1 310-282-0525

Fax+1 310-201-0662

Education & Training

UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Gastroenterology, 1996 - 1999
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1993 - 1996
University of Texas Health Science Center at HoustonPost-Doctoral Fellowship, Infectious Disease, 1991 - 1993
University of Crete School of Health SciencesClass of 1991

Certifications & Licensure

CA State Medical License 1996 - 2026

Clinical Trials

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease Start of enrollment: 2008 Dec 01
Completed
Phase 3
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis Start of enrollment: 2009 Jan 01
Completed
Phase 3
Efficacy and Safety Study With Diltiazem Hydrochloride Cream to Treat Anal Fissures Start of enrollment: 2012 Oct 01
Completed
Phase 3
A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors Start of enrollment: 2014 May 21
Completed
Phase 3
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment Start of enrollment: 2015 Sep 22
Terminated
Phase 3
Join now to see all

Research History

P.I.IBD vedolizumab IBD ETRO2007 - 2019

Other Languages

Spanish, Greek